The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease
Published version of a preprint
Abstract
Sirtuin 2 (SIRT2) has been proposed to have a central role on aging, inflammation, cancer and neurodegenerative diseases; however, its specific function remains controversial. Recent studies propose SIRT2 pharmacological inhibition as a therapeutic strategy for several neurodegenerative diseases including Alzheimer’s disease (AD). Surprisingly, none of these published studies regarding the potential interest of SIRT2 inhibition has assessed the peripheral adverse side consequences of this treatment. In this study, we demonstrate that the specific SIRT2 inhibitor, the compound 33i, does not exhibit genotoxic or mutagenic properties. Moreover, pharmacological treatment with 33i, improved cognitive dysfunction and long-term potentiation, reducing amyloid pathology and neuroinflammation in the APP/PS1 AD mouse model. However, this treatment increased peripheral levels of the inflammatory cytokines IL-1β, TNF, IL-6 and MCP-1. Accordingly, peripheral SIRT2 inhibition with the blood brain barrier impermeable compound AGK-2, worsened the cognitive capacities and increased systemic inflammation. The analysis of human samples revealed that SIRT2 is increased in the brain but not in the serum of AD patients. These results suggest that, although SIRT2 pharmacological inhibition may have beneficial consequences in neurodegenerative diseases, its pharmacological inhibition at the periphery would not be recommended and the systemic adverse side effects should be considered. This information is essential to maximize the therapeutic potential of SIRT2 inhibition not only for AD but also for other neurodegenerative diseases. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, a recent study published by our group has demonstrated that systemic SIRT2 pharmacological inhibition improves cognitive dysfunction and reduces amyloid pathology and neuroinflammation in a transgenic mouse model of AD (Sola-Sevilla et al., 2023).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Sola-Sevilla et al., 2023
In the citing paper
“Accordingly, SIRT2 inhibition or its genetic deletion has provided beneficial effects in different mouse models of Huntington's disease (Chopra et al., 2012;Luthi-Carter et al., 2010), Parkinson's disease (de Oliveira et al., 2017;Esteves et al., 2019;Sun et al., 2018); and Alzheimer's disease (AD) (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Sola-Sevilla et al., 2023
In the citing paper
“However, the potential adverse effects associated to its peripheral pharmacological inhibition (Sola-Sevilla et al., 2023) necessitate careful consideration to ensure the development of safe and effective therapeutic strategies.”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Sola-Sevilla et al., 2023
In the citing paper
“These findings contrast with those previous studies showing that SIRT2 pharmacological inhibition or whole-body genetic deletion enhances learning and memory and reduces mortality and amyloid pathology in mouse models of AD (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Sola-Sevilla et al., 2023
In the citing paper
“and its inhibition has shown beneficial effects in age-related neurodegenerative diseases such as AD (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020;Sola-Sevilla and Puerta, 2024).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Sola-Sevilla et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., & Heneka, M. T. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1569-12.2012 · Cited by 326 · cited 1×
“It has been described that, in early stage of AD, microglial activation delays disease progression by promoting clearance of Aβ by phagocytosis (Park et al. 2019; Yamanaka et al. 2012).”
BackgroundCharacterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice
Yan, P., Bero, A. W., Cirrito, J. R., Xiao, Q., Hu, X., Wang, Y., Gonzales, E., Holtzman, D. M., & Lee, J.-M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2637-09.2009 · Cited by 264
Luo, H., Mu, W.-C., Karki, R., Chiang, H.-H., Mohrin, M., Shin, J. J., Ohkubo, R., Ito, K., Kanneganti, T.-D., & Chen, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.101 · Cited by 161 · cited 1×
“Some authors have described that SIRT2 is decreased in aged-hematopoietic stem cells (Chambers et al. 2007; Luo et al. 2019), in blood mononuclear cells (Yudoh et al. 2015) and in macrophages isolated from old mice (He et al. 2020).”
BackgroundExploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice
Lalonde, R., Kim, H. D., & Fukuchi, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.069 · Cited by 121 · cited 1×
“Regarding other non-cognitive symptoms, we observed a decreased anxiety-like behavior in APP/PS1 mice, supporting previous studies (Reiserer et al. 2007; Lalonde et al. 2004).”
ResultPuntambekar, S. S., Moutinho, M., Lin, P. B.-C., Jadhav, V., Tumbleson-Brink, D., Balaji, A., Benito, M. A., Xu, G., Oblak, A., Lasagna-Reeves, C. A., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00545-9 · Cited by 113 · cited 1×
“Specifically, in AD, they have been proposed to have a key role on Aβ phagocytosis and, therefore, on AD pathology progression (Park et al. 2019; Singh et al. 2022; Puntambekar et al. 2022).”
BackgroundSingh, N., Das, B., Zhou, J., Hu, X., & Yan, R. (2022) · Science Advances · doi:10.1126/sciadv.abo3610 · Cited by 95 · cited 1×
“Specifically, in AD, they have been proposed to have a key role on Aβ phagocytosis and, therefore, on AD pathology progression (Park et al. 2019; Singh et al. 2022; Puntambekar et al. 2022).”
Background
Research works printed but not linked: 61
- Azqueta A, Stopper H, Zegura B, Dusinska M, Møller P (2022) Do cytotoxicity and cell death cause false positive results in the in vitro comet assay? Mutat Res Genet Toxicol Environ Mutagen 881:503520. https://doi.org/10.1016/j.mrgentox.2022.503520 · DOI · Paper page
- Bai N, Li N, Cheng R, Guan Y, Zhao X, Song Z, Xu H, Yi F, Jiang B, Li X, Wu X, Jiang C, Zhou T, Guo Q, Guo W, Feng Y, Wang Z, Ma M, Yu Y, Wang Z, Zhang S, Wang C, Zhao W, Liu S, Song X, Liu H, Cao L (2022) Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice. Cell Rep 40(2):111062. https://doi.org/10.1016/j.celrep.2022.111062 · DOI · Paper page
- Biella G, Fusco F, Nardo E, Bernocchi O, Colombo A, Lichtenthaler SF, Forloni G, Albani D (2016) Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models. J Alzheimers Dis 53(3):1193–1207. https://doi.org/10.3233/JAD-151135 · DOI · Paper page
- Bose P, Dai Y, Grant S (2014) Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. Pharmacol Ther 143(3):323–336. https://doi.org/10.1016/j.pharmthera.2014.04.004 · DOI · Paper page
- Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5(8):e201. https://doi.org/10.1371/journal.pbio.0050201 · DOI · Paper page
- Chen H, Wu D, Ding X, Ying W (2015) SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. NeuroReport 26(2):88–93. https://doi.org/10.1097/WNR.0000000000000305 · DOI
- Chen X, Lu W, Wu D (2021) Sirtuin 2 (SIRT2): Confusing roles in the pathophysiology of neurological disorders. Front Neurosci 15:614107. https://doi.org/10.3389/fnins.2021.614107 · DOI
- Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA, Choi SH, Silverman RB, Ferrante RJ, Hersch S, Kazantsev AG (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington’s disease mouse models. Cell Rep 2(6):1492–1497. https://doi.org/10.1016/j.celrep.2012.11.001 · DOI · Paper page
- Ciarlo E, Heinonen T, Théroude C, Herderschee J, Mombelli M, Lugrin J, Pfefferlé M, Tyrrell B, Lensch S, Acha-Orbea H, Le Roy D, Auwerx J, Roger T (2017) Sirtuin 2 deficiency increases bacterial phagocytosis by macrophages and protects from chronic staphylococcal infection. Front Immunol 28(8):1037. https://doi.org/10.3389/fimmu.2017.01037 · DOI
- de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szegö ÉM, Martinho R, Munari F, Lázaro DF, Moniot S, Guerreiro P, Fonseca-Ornelas L, Marijanovic Z, Antas P, Gerhardt E, Enguita FJ, Fauvet B, Penque D, Pais TF, Tong Q, Becker S, Kügler S, Lashuel HA, Steegborn C, Zweckstetter M, Outeiro TF (2017) The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol. 15(3):e2000374. https://doi.org/10.1371/journal.pbio.2000374. Erratum in: PLoS Biol. 2017 Apr 5;15(4):e1002601 · DOI · Paper page
- Diaz-Perdigon T, Belloch FB, Ricobaraza A, Elboray EE, Suzuki T, Tordera RM, Puerta E (2020) Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model. Neuropsychopharmacology 45(2):347–357. https://doi.org/10.1038/s41386-019-0503-8 · DOI · Paper page
- Eratne D, Loi SM, Farrand S, Kelso W, Velakoulis D, Looi JC (2018) Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis. Australas Psychiatry 26(4):347–357. https://doi.org/10.1177/1039856218762308 · DOI · Paper page
- Erburu M, Muñoz-Cobo I, Diaz-Perdigon T, Mellini P, Suzuki T, Puerta E, Tordera RM (2017) SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 1(117):195–208. https://doi.org/10.1016/j.neuropharm.2017.01.033 · DOI · Paper page
- Esteves AR, Palma AM, Gomes R, Santos D, Silva DF, Cardoso SM (2019) Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer’s and Parkinson disease pathology. Biochim Biophys Acta Mol Basis Dis 1865(8):2008–2023. https://doi.org/10.1016/j.bbadis.2018.11.014 · DOI · Paper page
- Gaetani L, Bellomo G, Parnetti L, Blennow K, Zetterberg H, Di Filippo M (2021) Neuroinflammation and Alzheimer’s disease: a machine learning approach to CSF proteomics. Cells 10(8):1930. https://doi.org/10.3390/cells10081930 · DOI
- Goikolea J, Gerenu G, Daniilidou M, Mangialasche F, Mecocci P, Ngandu T, Rinne J, Solomon A, Kivipelto M, Cedazo-Minguez A, Sandebring-Matton A, Maioli S (2022) Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD. Alzheimers Res Ther 14(1):37. https://doi.org/10.1186/s13195-022-00979-9 · DOI
- Gray SC, Kinghorn KJ, Woodling NS (2020) Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis. Neural Regen Res 15(7):1208–1219. https://doi.org/10.4103/1673-5374.272571 · DOI · Paper page
- Guclu E, Inan SY, Vural HC (2022) The sirtuin 2 inhibitor AK-7 leads to an antidepressant-like effect in mice via upregulation of CREB1, BDNF, and NTRK2 pathways. Mol Neurobiol. https://doi.org/10.1007/s12035-022-03026-8 · DOI · Paper page
- He M, Chiang HH, Luo H, Zheng Z, Qiao Q, Wang L, Tan M, Ohkubo R, Mu WC, Zhao S, Wu H, Chen D (2020) An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance. Cell Metab 31(3):580-591.e5. https://doi.org/10.1016/j.cmet.2020.01.009 · DOI · Paper page
- Jayasena T, Poljak A, Braidy N, Zhong L, Rowlands B, Muenchhoff J, Grant R, Smythe G, Teo C, Raftery M, Sachdev P (2016) Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system. Sci Rep 20(6):35391. https://doi.org/10.1038/srep35391 · DOI · Paper page
- Jiao F, Wang Y, Zhang W, Zhang H, Chen Q, Wang L, Shi C, Gong Z (2020) AGK2 alleviates lipopolysaccharide induced neuroinflammation through regulation of mitogen-activated protein kinase phosphatase-1. J Neuroimmune Pharmacol 15(2):196–208. https://doi.org/10.1007/s11481-019-09890-x · DOI
- Johnson D, Walmsley R (2013) Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay. Mutat Res 751(2):96–100. https://doi.org/10.1016/j.mrgentox.2012.12.009 · DOI
- Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281(36):26602–26614. https://doi.org/10.1074/jbc.M601284200 · DOI · Paper page
- Lau SF, Wu W, Seo H, Fu AKY, Ip NY (2021) Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer’s disease mouse model. STAR Protoc 2(1):100265. https://doi.org/10.1016/j.xpro.2020.100265 · DOI
- Lee AS, Jung YJ, Kim D, Nguyen-Thanh T, Kang KP, Lee S, Park SK, Kim W (2014) SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem Biophys Res Commun 450(4):1363–1369. https://doi.org/10.1016/j.bbrc.2014.06.135 · DOI
- Liu G, Park SH, Imbesi M, Nathan WJ, Zou X, Zhu Y, Jiang H, Parisiadou L, Gius D (2017) Loss of NAD-dependent protein deacetylase sirtuin-2 alters mitochondrial protein acetylation and dysregulates mitophagy. Antioxid Redox Signal 26(15):849–863. https://doi.org/10.1089/ars.2016.666 · doi:10.1089/ars.2016.666
- Lo Sasso G, Menzies KJ, Mottis A, Piersigilli A, Perino A, Yamamoto H, Schoonjans K, Auwerx J (2014) SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS One 9(7):e103573. https://doi.org/10.1371/journal.pone.0103573 · DOI
- Luthi-Carter R, Taylor DM, Pallos J, Lambert E, Amore A, Parker A, Moffitt H, Smith DL, Runne H, Gokce O, Kuhn A, Xiang Z, Maxwell MM, Reeves SA, Bates GP, Neri C, Thompson LM, Marsh JL, Kazantsev AG (2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci U S A 107(17):7927–7932. https://doi.org/10.1073/pnas.1002924107 · DOI · Paper page
- Márquez-Ropero M, Benito E, Plaza-Zabala A, Sierra A (2020) Microglial corpse clearance: Lessons from macrophages. Front Immunol 27(11):506. https://doi.org/10.3389/fimmu.2020.00506 · DOI
- Maxwell MM, Tomkinson EM, Nobles J, Wizeman JW, Amore AM, Quinti L, Chopra V, Hersch SM, Kazantsev AG (2011) The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 20(20):3986–3996. https://doi.org/10.1093/hmg/ddr326 · DOI · Paper page
- Meng SX, Wang B, Li WT (2020) Intermittent hypoxia improves cognition and reduces anxiety-related behavior in APP/PS1 mice. Brain Behav 10(2):e01513. https://doi.org/10.1002/brb3.1513. Epub 2019 Dec 26 · DOI
- Muñoz-Cobo I, Belloch FB, Díaz-Perdigón T, Puerta E, Tordera RM (2017) SIRT2 inhibition reverses anhedonia in the VGLUT1+/- depression model. Behav Brain Res 29(335):128–131. https://doi.org/10.1016/j.bbr.2017.07.045 · DOI
- North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11(2):437–444. https://doi.org/10.1016/s1097-2765(03)00038-8 · DOI · Paper page
- North BJ, Rosenberg MA, Jeganathan KB, Hafner AV, Michan S, Dai J, Baker DJ, Cen Y, Wu LE, Sauve AA, van Deursen JM, Rosenzweig A, Sinclair DA (2014) SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J 33(13):1438–1453. https://doi.org/10.15252/embj.201386907 · DOI · Paper page
- Olaharski AJ, Ji Z, Woo JY, Lim S, Hubbard AE, Zhang L, Smith MT (2006) The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro. Toxicol Sci 93(2):341–347. https://doi.org/10.1093/toxsci/kfl068 · DOI
- Olesen LØ, Bouzinova EV, Severino M, Sivasaravanaparan M, Hasselstrøm JB, Finsen B, Wiborg O (2016) Behavioural phenotyping of APPswe/PS1δE9 Mice: Age-rrelated changes and effect of long-term paroxetine treatment. PLoS One 11(11):e0165144. https://doi.org/10.1371/journal.pone.0165144 · DOI
- Pais TF, Szegő ÉM, Marques O, Miller-Fleming L, Antas P, Guerreiro P, de Oliveira RM, Kasapoglu B, Outeiro TF (2013) The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32(19):2603–2616. https://doi.org/10.1038/emboj.2013.200 · DOI · Paper page
- Park MH, Lee M, Nam G, Kim M, Kang J, Choi BJ, Jeong MS, Park KH, Han WH, Tak E, Kim MS, Lee J, Lin Y, Lee YH, Song IS, Choi MK, Lee JY, Jin HK, Bae JS, Lim MH (2019) N, N’-Diacetyl-p-phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer’s disease transgenic mice. Proc Natl Acad Sci U S A 116(47):23426–23436. https://doi.org/10.1073/pnas.1916318116 · DOI
- Rack JG, VanLinden MR, Lutter T, Aasland R, Ziegler M (2014) Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform. J Mol Biol 426(8):1677–1691. https://doi.org/10.1016/j.jmb.2013.10.027 · DOI
- Reiserer RS, Harrison FE, Syverud DC, McDonald MP (2007) Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer’s disease. Genes Brain Behav 6(1):54–65. https://doi.org/10.1111/j.1601-183X.2006.00221.x · DOI · Paper page
- Rosenberg A, Solomon A, Jelic V, Hagman G, Bogdanovic N, Kivipelto M (2019) Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid. Alzheimers Res Ther 11(1):99. https://doi.org/10.1186/s13195-019-0557-1 · DOI
- Rothgiesser KM, Erener S, Waibel S, Lüscher B, Hottiger MO (2010) SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 123(Pt 24):4251–8. https://doi.org/10.1242/jcs.073783. Epub 2010 Nov 16. Erratum in: J Cell Sci. 2019 Apr 24;132(8) · DOI · Paper page
- Shen Y, Chen L, Zhang S, Xie L (2020) Correlation between SIRT2 3’UTR gene polymorphism and the susceptibility to Alzheimer’s Disease. J Mol Neurosci 70(6):878–886. https://doi.org/10.1007/s12031-020-01513-y · DOI
- Silva DF, Esteves AR, Oliveira CR, Cardoso SM (2017) Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer’s-disease related pathology. Mol Neurobiol 54(6):4021–4040. https://doi.org/10.1007/s12035-016-9951-x · DOI
- Sola-Sevilla N, Puerta E (2024) SIRT2 as a potential new therapeutic target for Alzheimer’s disease. Neural Regen Res 19(1):124–131. https://doi.org/10.4103/1673-5374.375315 · DOI
- Sola-Sevilla N, Ricobaraza A, Hernandez-Alcoceba R, Aymerich MS, Tordera RM, Puerta E (2021) Understanding the potential role of sirtuin 2 on aging: Consequences of SIRT2.3 overexpression in senescence. Int J Mol Sci 22(6):3107. https://doi.org/10.3390/ijms22063107 · DOI
- Spires-Jones TL, Fox LM, Rozkalne A, Pitstick R, Carlson GA, Kazantsev AG (2012) Inhibition of sirtuin 2 with sulfobenzoic acid derivative ak1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 12(3):42. https://doi.org/10.3389/fphar.2012.00042 · DOI
- Sun S, Han X, Li X, Song Q, Lu M, Jia M, Ding J, Hu G (2018) MicroRNA-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson’s disease. Front Mol Neurosci 11(11):381. https://doi.org/10.3389/fnmol.2018.00381 · DOI · Paper page
- Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, Miyata N (2012) Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem 55(12):5760–5773. https://doi.org/10.1021/jm3002108 · DOI
- Wang B, Zhang Y, Cao W, Wei X, Chen J, Ying W (2016) SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice. Neurochem Res 41(9):2490–2500. https://doi.org/10.1007/s11064-016-1981-2 · DOI
- Wang G, Li S, Gilbert J, Gritton HJ, Wang Z, Li Z, Han X, Selkoe DJ, Man HY (2017) Crucial roles for SIRT2 and AMPA receptor acetylation in synaptic plasticity and memory. Cell Rep 20(6):1335–1347. https://doi.org/10.1016/j.celrep.2017.07.030 · DOI · Paper page
- Wang Y, Yang J, Hong T, Chen X, Cui L (2019) SIRT2: Controversy and multiple roles in disease and physiology. Ageing Res Rev 55:100961. https://doi.org/10.1016/j.arr.2019.100961 · DOI · Paper page
- Wang Y, Yang JQ, Hong TT, Sun YH, Huang HL, Chen F, Chen XJ, Chen HY, Dong SS, Cui LL, Yang TL (2020) RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer’s disease mouse model. Aging Cell 19(8):e13194. https://doi.org/10.1111/acel.13194 · DOI · Paper page
- Wongchitrat P, Pakpian N, Kitidee K, Phopin K, Dharmasaroja PA, Govitrapong P (2019) Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood. Curr Alzheimer Res 16(1):29–38. https://doi.org/10.2174/1567205015666181109103742 · DOI
- Wu Z, Zhang Y, Zhang Y, Zhao P (2020) Sirtuin 2 inhibition attenuates sevoflurane-induced learning and memory deficits in developing rats via modulating microglial activation. Cell Mol Neurobiol 40(3):437–446. https://doi.org/10.1007/s10571-019-00746-9 · DOI
- Yoo EJ, Lee BM (2005) Comparative mutagenicity of apicidin and apicidin derivatives (SD-0203 and SD-2007), histone deacetylase inhibitors. J Toxicol Environ Health A 68(23–24):2097–2109. https://doi.org/10.1080/15287390500182511 · DOI
- Yuan F, Xu ZM, Lu LY, Nie H, Ding J, Ying WH, Tian HL (2016) SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem 136(3):581–593. https://doi.org/10.1111/jnc.13423 · DOI
- Yudoh K, Karasawa R, Ishikawa J (2015) Age-related decrease of sirtuin 2 protein in human peripheral blood mononuclear cells. Curr Aging Sci 8(3):256–258. https://doi.org/10.2174/1874609808999150831112939.Erratum.In:CurrAgingSci.2016;9(1):77 · doi:10.2174/1874609808999150831112939.erratum.in:curragingsci.2016;9(1):77
- Zamora-Moratalla A, Martín ED (2021) Prolactin enhances hippocampal synaptic plasticity in female mice of reproductive age. Hippocampus 31(3):281–293. https://doi.org/10.1002/hipo.23288 · DOI
- Zhang L, Kim S, Ren X (2020) The clinical significance of SIRT2 in malignancies: A Tumor suppressor or an oncogene? Front Oncol 8(10):1721. https://doi.org/10.3389/fonc.2020.01721 · DOI
- Zhang Y, Chi D (2018) Overexpression of SIRT2 alleviates neuropathic pain and neuroinflammation through deacetylation of transcription factor nuclear factor-kappa B. Inflammation 41(2):569–578. https://doi.org/10.1007/s10753-017-0713-3 · DOI
Cited by
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Self-citation
Metadata
- Authors
- Sola-Sevilla, N., Mesa-Lombardo, A., Aleixo, M., Expósito, S., Diaz-Perdigón, T., Azqueta, A., Zamani, F., Suzuki, T., Maioli, S., Eroli, F., Matton, A., Ramírez, M. J., Solas, M., Tordera, R. M., Martín, E. D., & Puerta, E.
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2023-09
- Volume
- 18
- Issue
- 3
- Pages
- 529-550
- ISSN
- 1557-1890
- 1557-1904
- Cited by
- 20
- References
- 6
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 11 d)
- Funders
- Universidad de Navarra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s11481-023-10084-9
- The paper
- Sola-Sevilla, N., Mesa-Lombardo, A., Aleixo, M., Expósito, S., Diaz-Perdigón, T., Azqueta, A., Zamani, F., Suzuki, T., Maioli, S., Eroli, F., Matton, A., Ramírez, M. J., Solas, M., Tordera, R. M., Martín, E. D., & Puerta, E. (2023). SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-023-10084-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.